Novartis Collaboration Agreement (Tables) (GEN-PROBE INCORPORATED [Member])

12 Months Ended

Dec. 31, 2011

GEN-PROBE INCORPORATED [Member]

Recognized Revenues Under Collaboration Agreement

During the years ended December 31, 2011, 2010 and 2009, the Company recognized revenues under this collaboration agreement in the following categories (in thousands):

	Years Ended December 31,
	2011		2010		2009
Product sales	$	199,411	$	203,140	$	197,537
Collaborative research revenue		7,362		13,921		6,711
Royalty and license revenue		2,550		2,396		4,202
Total revenue from Novartis	$	209,323	$	219,457	$	208,450